Demo Sign up Log In

Antares Pharma, Inc. (ATRS)

Cost of Revenue

$70.60M

TTM · Period ending: Mar 31, 2022 · USD

ATRS Cost of Revenue

Latest reported$70.60Mperiod endingMar 31, 2022

Latest reported$70.60Mperiod endingMar 31, 2022

ATRS Cost of Revenue ($1.14M → $70.60M)

Annual cost of revenue

High-resolution chart · PNG

ATRS cost of revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. Cost of Revenue — Annual fiscal periods (USD)
Period ending	Cost of Revenue (USD)
Dec 31, 2021	68,281,000
Dec 31, 2020	63,100,000
Dec 31, 2019	50,475,000
Dec 31, 2018	31,065,000
Dec 31, 2017	27,466,000
Dec 31, 2016	28,816,766
Dec 31, 2015	19,457,683
Dec 31, 2014	11,236,695
Dec 31, 2013	9,197,230
Dec 31, 2012	9,520,472
Dec 31, 2011	6,797,192
Dec 31, 2010	4,273,210
Dec 31, 2009	4,139,834
Dec 31, 2008	2,019,585
Dec 31, 2007	3,442,020
Dec 31, 2006	1,555,970
Dec 31, 2005	1,136,745
Dec 31, 2004	1,372,302
Dec 31, 2003	2,007,883
Dec 31, 2002	2,573,280
Dec 31, 2001	1,862,955
Dec 31, 2000	1,646,589
Dec 31, 1999	1,785,464
Dec 31, 1998	1,852,026
Dec 31, 1997	1,221,051
Dec 31, 1996	1,136,272

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.